Related Experiment Video
Updated: Aug 11, 2026

10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
A new generation of vaccines
The Veterinary Clinics of North America. Small Animal Practice
|November 1, 1986
Summary
New vaccine technologies using recombinant DNA and gene sequencing offer safer, more stable, and predictable production. This advancement promises wider vaccine use and improved control over infectious diseases.
Area of Science:
- Biotechnology
- Vaccinology
- Molecular Biology
Background:
- Current vaccine production methods face limitations in stability and predictability.
- Advancements in molecular biology are paving the way for next-generation vaccines.
Purpose of the Study:
- To explore the potential of new technologies in vaccine development.
- To highlight the advantages of novel vaccine platforms.
Main Methods:
- Utilizing recombinant DNA technology for antigen design.
- Employing gene sequencing for precise genetic manipulation.
- Leveraging peptide synthesis for targeted epitope production.
Main Results:
- New vaccine candidates exhibit enhanced safety profiles.
- Improved stability characteristics compared to traditional vaccines.
- Predictable and scalable manufacturing processes.
Conclusions:
- Emerging biotechnologies are revolutionizing vaccine design and production.
- Next-generation vaccines are expected to increase accessibility and efficacy.
- Significant potential for enhanced control of infectious diseases globally.
More Related Videos
Related Concept Videos
Cross-reactivity
Overview
Vaccinations
Overview
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

